Helen Louise Collins sold $228K of ELVN

sold $227.65k of ELVN

3,900 shares @ $58.37

Decreased holdings by -13.00%

Net across this filing: 0.00% (+0 shares)

6th largest trade (out of 60)

Planned (10b5-1)

“The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 19, 2025.”Form 4 footnote

Trade made by an officer

Executed under a pre-scheduled Rule 10b5-1 plan

Net holdings across this filing: +0.0% (+0 shares)

Price 71% above 200-day moving average

ELVNEnliven Therapeutics, Inc.

HealthcareBiotechnology

1D0.00%

1W+1.70%

1M+12.97%

3M—

6M—

1Y—

Recent insider activity at ELVN

Aug 17Benjamin HohlSold$270.17k Aug 17Helen Louise CollinsSold$65.28k Aug 17Benjamin HohlSold$82.38k Aug 4Mika K. DerynckSold$9.56m Jul 17Benjamin HohlSold$134.14k Jul 17Benjamin HohlSold$140.82k Jul 17Benjamin HohlSold$16.19k Jul 17Benjamin HohlSold$6.63k

Full ELVN profile →Helen Louise Collins’s trading history →

Recent insider activity at ELVN

The morning brief, before the bell.